Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Single Dose Intravesical Apaziquone Postoperative in Patients Undergoing TURBT for Noninvasive Bladder Cancer (SPI-612)

ClinicalTrials.gov ID: NCT00598806

Public ClinicalTrials.gov record NCT00598806. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 1:54 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Phase 3 Trial of Single-Dose Intravesical Apaziquone (EOquin®) as a Surgical Adjuvant Instilled in the Early Postoperative Period in Patients Undergoing Transurethral Resection for Noninvasive Bladder Cancer (Protocol SPI-612)

Study identification

NCT ID
NCT00598806
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Spectrum Pharmaceuticals, Inc
Industry
Enrollment
812 participants

Conditions and interventions

Conditions

Interventions

  • Apaziquone Drug
  • Placebo Drug
  • TURBT Procedure

Drug · Procedure

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2007
Primary completion
Dec 31, 2011
Completion
Dec 31, 2011
Last update posted
Nov 12, 2017

2007 – 2012

United States locations

U.S. sites
21
U.S. states
15
U.S. cities
20
Facility City State ZIP Site status
Advanced Urology Medical Center Clinical Trials Anaheim California 92801
Hal J. Bashein, D.O. West Palm Beach Florida 33407
Urology Enterprises Marietta Georgia 30060
North Fulton Urology Roswell Georgia 30076
Hines VA Hospital Hines Illinois 60141
The Urology Center Slidell Louisiana 70458
Chesapeake Urology Research Associates Baltimore Maryland 21237
Chesapeake Urology Research Associates Towson Maryland 21204
William Beaumont Hospital Royal Oak Michigan 48073
PharmaTrials, Inc. - Male & Female Urology Hillsborough New Jersey 08844
PharmaTrials, Inc. Hillsborough New Jersey 08844
Medical & Clinical Research Associates, LLC Bay Shore New York 11706
Urology Associates, PC Manhasset New York 11030
North Shore - LIJ Health System - The Arthur Smith Institute for Urology New Hyde Park New York 11040
Alliance Urology Specialists Greensboro North Carolina 27403
Piedmont Medical Research Winston-Salem North Carolina 27103
Center for Urologic Care Bryn Mawr Pennsylvania 19010
Medical University of South Carolina, Dept. of Urology Charleston South Carolina 29425
Urology Associates of South Texas McAllen Texas 78503
Salt Lake Research Salt Lake City Utah 84107
Adult and Pediatric Urologists Alexandria Virginia 22304

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 56 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00598806, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 12, 2017 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00598806 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →